{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:33Z","timestamp":1786984233380,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ajp.2021.102652","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T11:35:34Z","timestamp":1617708934000},"page":"102652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Risk factors for clozapine-induced central nervous system abnormalities in Japanese patients with treatment-resistant schizophrenia"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9336-3083","authenticated-orcid":false,"given":"Kohei","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Uekusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5796-9646","authenticated-orcid":false,"given":"Kei","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Yada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2021.102652_bib0005","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1176\/appi.ajp.158.8.1305","article-title":"A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia","volume":"158","author":"Azorin","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102652_bib0010","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.clinph.2017.07.418","article-title":"Standardized computer-based organized reporting of EEG: SCORE - Second version","volume":"128","author":"Beniczky","year":"2017","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"10.1016\/j.ajp.2021.102652_bib0015","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","article-title":"Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials","volume":"158","author":"Chakos","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102652_bib0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/WNL.41.3.369","article-title":"Clozapine-related seizures","volume":"41","author":"Devinsky","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ajp.2021.102652_bib0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0006-3223(96)00298-3","article-title":"Clozapine-induced electroencephalogram changes as a function of clozapine serum levels","volume":"42","author":"Freudenreich","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102652_bib0030","first-page":"426","article-title":"Seizures in two patients after the addition of lithium to a clozapine regimen","volume":"14","author":"Garcia","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2021.102652_bib0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4306\/pi.2011.8.4.372","article-title":"Electroencephalographic abnormalities in clozapine-treated patients: a cross-sectional study","volume":"8","author":"Goyal","year":"2011","journal-title":"Psychiatry Invest."},{"key":"10.1016\/j.ajp.2021.102652_bib0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/0269881103017002014","article-title":"Serum clozapine levels: a review of their clinical utility","volume":"17","author":"Greenwood-Smith","year":"2003","journal-title":"J. Psychopharmacology (Oxf.)"},{"key":"10.1016\/j.ajp.2021.102652_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2019.02.005","article-title":"EEG changes in patients on antipsychotic therapy: a systematic review","volume":"95","author":"Jackson","year":"2019","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.ajp.2021.102652_bib0050","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102652_bib0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cnp.2017.07.002","article-title":"A revised glossary of terms most commonly used by clinical electroencephalographers and updated proposal for the report format of the EEG findings. Revision 2017","volume":"2","author":"Kane","year":"2017","journal-title":"Clin. Neurophysiol. Pract."},{"key":"10.1016\/j.ajp.2021.102652_bib0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.30773\/pi.2018.12.16","article-title":"Relationship between clozapine-induced electroencephalogram abnormalities and serum concentration of clozapine in Japanese patients with treatment-resistant schizophrenia","volume":"16","author":"Kikuchi","year":"2019","journal-title":"Psychiatry Invest."},{"key":"10.1016\/j.ajp.2021.102652_bib0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/YIC.0000000000000255","article-title":"Association between electroencephalogram changes and plasma clozapine levels in clozapine-treated patients","volume":"34","author":"Kim","year":"2019","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2021.102652_bib0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.psychres.2013.02.030","article-title":"The CYP1A2-163C&A polymorphism is associated with clozapine-induced generalized tonic-clonic seizures in Brazilian schizophrenia patients","volume":"209","author":"Kohlrausch","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ajp.2021.102652_bib0075","first-page":"1525","article-title":"Lithium carbonate and leukocytosis","volume":"37","author":"Lapierre","year":"1980","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.ajp.2021.102652_bib0080","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/schbul\/sbj067","article-title":"Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia","volume":"32","author":"Lewis","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2021.102652_bib0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00002018-199309060-00005","article-title":"Adverse effects of antipsychotic drugs","volume":"9","author":"Malhotra","year":"1993","journal-title":"Drug Saf."},{"key":"10.1016\/j.ajp.2021.102652_bib0090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102652_bib0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/2045125315612015","article-title":"Clozapine-induced myoclonus: a case report and review of the literature","volume":"5","author":"Osborne","year":"2015","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ajp.2021.102652_bib0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/104012371002200310","article-title":"Leukocytosis after lithium and clozapine combination therapy","volume":"22","author":"Palominao","year":"2010","journal-title":"Ann. Clin. Psychiatry Off. J. Am. Acad. Clin. Psychiatr."},{"key":"10.1016\/j.ajp.2021.102652_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1742-7843.2004.pto_940104.x","article-title":"Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients","volume":"94","author":"Raaska","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ajp.2021.102652_bib0110","article-title":"Clozapine-induced microseizures, orofacial dyskinesia, and speech dysfluency in an adolescent with treatment resistant early onset schizophrenia on concurrent Lithium therapy","volume":"2017","author":"Rachamallu","year":"2017","journal-title":"Case Rep. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102652_bib0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1017\/S1742646413000332","article-title":"Drug interactions affecting clozapine levels","volume":"11","author":"Singh","year":"2015","journal-title":"J. Psychiatry Intensive Care"},{"key":"10.1016\/j.ajp.2021.102652_bib0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.jcp.0000084026.22282.5f","article-title":"Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder","volume":"23","author":"Small","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2021.102652_bib0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1017\/S1092852912000806","article-title":"Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses","volume":"18","author":"Souza","year":"2013","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ajp.2021.102652_bib0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1192\/bjp.171.2.109","article-title":"Pharmacokinetic interactions involving clozapine","volume":"171","author":"Taylor","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102652_bib0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0924-977X(95)00057-V","article-title":"EEG abnormalities in clozapine-treated schizophrenic patients","volume":"6","author":"Treves","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2021.102652_bib0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/2045125311405566","article-title":"Clozapine-related EEG changes and seizures: dose and plasma-level relationships","volume":"1","author":"Varma","year":"2011","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ajp.2021.102652_bib0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: a review of clinical practice guidelines and prescribing trends","volume":"14","author":"Warnez","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ajp.2021.102652_bib0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40263-014-0222-y","article-title":"Seizure associated with clozapine: incidence, etiology, and management","volume":"29","author":"Williams","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2021.102652_bib0155","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization","year":"1992"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:38:22Z","timestamp":1761755902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201821001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":31,"alternative-id":["S1876201821001088"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102652","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for clozapine-induced central nervous system abnormalities in Japanese patients with treatment-resistant schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102652"}}